{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:11:38Z","timestamp":1791389498712,"version":"4.3.3"},"reference-count":141,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,4]],"date-time":"2020-01-04T00:00:00Z","timestamp":1578096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBEROBN CB12\/03\/30038"],"award-info":[{"award-number":["CIBEROBN CB12\/03\/30038"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.apsb.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T02:24:05Z","timestamp":1578450245000},"page":"734-745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Natural products, PGC-1 , and Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"10","author":[{"given":"Ipek","family":"Suntar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Belwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Sanches Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Anna","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devesh","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Sobarzo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Fazel","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Shirooie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suowen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Majidinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Daglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D'Antona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2020.01.001_bib1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/er.2006-0037","article-title":"Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism","volume":"27","author":"Handschin","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.apsb.2020.01.001_bib2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.gde.2008.07.018","article-title":"PGC-1 coactivators and skeletal muscle adaptations in health and disease","volume":"18","author":"Arany","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.apsb.2020.01.001_bib3","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1074\/jbc.M112.375253","article-title":"The PGC-1 coactivators repress the transcriptional activity of NF-\u03baB in skeletal muscle cells","volume":"288","author":"Eisele","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2020.01.001_bib4","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.3390\/ijms12107199","article-title":"Roles of oxidative stress, apoptosis, PGC-1\u03b1 and mitochondrial biogenesis in cerebral ischemia","volume":"12","author":"Chen","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2020.01.001_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature00904","article-title":"Transcriptional co-activator PGC-1\u03b1 drives the formation of slow-twitch muscle fibres","volume":"418","author":"Lin","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.01.001_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCRESAHA.115.303829","article-title":"PGC-1\u03b1 induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle","volume":"115","author":"Rowe","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2020.01.001_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2005.12.003","article-title":"Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost","volume":"16","author":"Kummer","year":"2006","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.apsb.2020.01.001_bib8","doi-asserted-by":"crossref","first-page":"C908","DOI":"10.1152\/ajpcell.00196.2005","article-title":"Calcineurin\u2013NFAT signaling, together with GABP and peroxisome PGC-1\u03b1, drives utrophin gene expression at the neuromuscular junction","volume":"289","author":"Angus","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.apsb.2020.01.001_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","article-title":"Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR\u03b3): a review","volume":"92","author":"Wang","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2020.01.001_bib10","first-page":"803","article-title":"Gene therapy for muscular dystrophy-a review of promising progress","volume":"3","author":"Gregorevic","year":"2003","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.apsb.2020.01.001_bib11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.molmed.2007.10.003","article-title":"New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials","volume":"13","author":"Cossu","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1517\/14712598.8.8.1051","article-title":"Combining stem cells and exon skipping strategy to treat muscular dystrophy","volume":"8","author":"Meregalli","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.apsb.2020.01.001_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin\u2013glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2020.01.001_bib14","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2020.01.001_bib15","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1093\/hmg\/ddr105","article-title":"Therapeutic approaches to muscular dystrophy","volume":"20","author":"Goyenvalle","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.apsb.2020.01.001_bib16","first-page":"179","article-title":"Recherches sur le paralysie musculaire pseudohypertrophique ou paralysie myosclerosique. I. Symptomatologie, marche, duree, terminaison","volume":"11","author":"Duchenne","year":"1868","journal-title":"Arch Gen Med 6 ser"},{"key":"10.1016\/j.apsb.2020.01.001_bib17","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","article-title":"Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy","volume":"320","author":"Mendell","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2020.01.001_bib19","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/nar\/20.7.1725","article-title":"Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development","volume":"20","author":"Bies","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2020.01.001_bib20","doi-asserted-by":"crossref","first-page":"230fs14","DOI":"10.1126\/scitranslmed.3008873","article-title":"Exon-skipping therapy: a roadblock, detour, or bump in the road?","volume":"6","author":"Hoffman","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/hum.2017.213","article-title":"Gene therapy for hemophilia and Duchenne muscular dystrophy in China","volume":"29","author":"Liu","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.apsb.2020.01.001_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.apsb.2020.01.001_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.apsb.2020.01.001_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","article-title":"The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review","volume":"12","author":"Ryder","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.apsb.2020.01.001_bib25","doi-asserted-by":"crossref","first-page":"1701418","DOI":"10.1183\/13993003.01418-2017","article-title":"Evolution of respiratory function in Duchenne muscular dystrophy from childhood to adulthood","volume":"51","author":"LoMauro","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.apsb.2020.01.001_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2020.01.001_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT\u2013NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.apsb.2020.01.001_bib29","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0960-8966(02)00086-X","article-title":"Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy","volume":"12","author":"Aartsma-Rus","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.apsb.2020.01.001_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2017.10.082","article-title":"Eteplirsen for paediatric patients with Duchenne muscular dystrophy: a pooled-analysis","volume":"49","author":"Randeree","year":"2017","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.apsb.2020.01.001_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/0028-3886.43443","article-title":"Exon skipping and Duchenne muscular dystrophy: hope, hype and how feasible?","volume":"56","author":"Wilton","year":"2008","journal-title":"Neurol India"},{"key":"10.1016\/j.apsb.2020.01.001_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3233\/JND-180351","article-title":"Eteplirsen treatment attenuates respiratory decline in ambulatory and non-ambulatory patients with Duchenne muscular dystrophy","volume":"6","author":"Khan","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.apsb.2020.01.001_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2017.126","article-title":"Genome engineering: a new approach to gene therapy for neuromuscular disorders","volume":"13","author":"Nelson","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2020.01.001_bib34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/mt.2014.234","article-title":"Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases","volume":"23","author":"Ousterout","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2020.01.001_bib35","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/mt.2013.111","article-title":"Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients","volume":"21","author":"Ousterout","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2020.01.001_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ymthe.2019.01.019","article-title":"Micro-dystrophin genes bring hope of an effective therapy for Duchenne muscular dystrophy","volume":"27","author":"Davies","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2020.01.001_bib37","first-page":"2471","article-title":"Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials","volume":"8","author":"Shimizu-Motohashi","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.apsb.2020.01.001_bib38","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM199509283331303","article-title":"Myoblast transfer in the treatment of Duchenne's muscular dystrophy","volume":"333","author":"Mendell","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3727\/000000007783465064","article-title":"Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients","volume":"16","author":"Torrente","year":"2007","journal-title":"Cell Transplant"},{"key":"10.1016\/j.apsb.2020.01.001_bib40","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.15252\/emmm.201505636","article-title":"Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy","volume":"7","author":"Cossu","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","article-title":"Human ES- and iPS-derived myogenic progenitors restore dystrophin and improve contractility upon transplantation in dystrophic mice","volume":"10","author":"Darabi","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.apsb.2020.01.001_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.apsb.2020.01.001_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","article-title":"Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9","volume":"4","author":"Li","year":"2015","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.apsb.2020.01.001_bib44","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.3390\/jpm8040038","article-title":"Applications of CRISPR\/Cas9 for the treatment of Duchenne muscular dystrophy","volume":"8","author":"Lim","year":"2018","journal-title":"J Personalized Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib45","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tcb.2006.02.001","article-title":"Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy","volume":"16","author":"Batchelor","year":"2006","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.apsb.2020.01.001_bib46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/345315a0","article-title":"Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle","volume":"345","author":"Ervasti","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.01.001_bib47","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00454.2004","article-title":"Inflammatory processes in muscle injury and repair","volume":"288","author":"Tidball","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.apsb.2020.01.001_bib48","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/hum.2011.127","article-title":"Prednisolone treatment does not interfere with 2\u2032-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy","volume":"23","author":"Verhaart","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.apsb.2020.01.001_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2044-5040-4-6","article-title":"Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis","volume":"4","author":"Cabrera","year":"2014","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.apsb.2020.01.001_bib50","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects","volume":"5","author":"Heier","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib51","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.0608277104","article-title":"Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy","volume":"104","author":"Brunelli","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2020.01.001_bib52","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.phrs.2012.01.006","article-title":"Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients","volume":"65","author":"D'Angelo","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2020.01.001_bib53","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm1479","article-title":"Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors","volume":"12","author":"Minetti","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib54","unstructured":"NIH U.S. National library of medicine. Clinical study to evaluate the efficacy and safety of givinostat in ambulant patients with Duchenne muscular dystrophy. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02851797."},{"key":"10.1016\/j.apsb.2020.01.001_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0805514105","article-title":"HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment","volume":"105","author":"Colussi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2020.01.001_bib56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2119\/molmed.2011.00049","article-title":"Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases","volume":"17","author":"Consalvi","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib57","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1043-2760(01)00457-X","article-title":"PGC-1, a versatile coactivator","volume":"12","author":"Knutti","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.apsb.2020.01.001_bib58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metabol"},{"key":"10.1016\/j.apsb.2020.01.001_bib59","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2006.04.002","article-title":"Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation","volume":"3","author":"Uldry","year":"2006","journal-title":"Cell Metabol"},{"key":"10.1016\/j.apsb.2020.01.001_bib60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional\u00a0coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.apsb.2020.01.001_bib61","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.2012.06738.x","article-title":"Role of PGC-1\u03b1 signaling in skeletal muscle health and disease","volume":"1271","author":"Kang","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.apsb.2020.01.001_bib62","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.1212976110","article-title":"Skeletal muscle PGC-1\u03b1 controls whole-body lactate homeostasis through estrogen-related receptor \u03b1-dependent activation of LDH B and repression of LDH A","volume":"110","author":"Summermatter","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2020.01.001_bib63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2020.01.001_bib64","doi-asserted-by":"crossref","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson's disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib65","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00125-006-0268-6","article-title":"PGC-1\u03b1: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes","volume":"49","author":"Soyal","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2020.01.001_bib66","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1242\/jcs.113662","article-title":"PGC1\u03b1 and mitochondrial metabolism-emerging concepts and relevance in ageing and neurodegenerative disorders","volume":"125","author":"Austin","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2020.01.001_bib67","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/febs.13175","article-title":"New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond","volume":"282","author":"Villena","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2020.01.001_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010025","article-title":"PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia","volume":"5","author":"Marmolino","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2020.01.001_bib69","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bbrc.2008.12.109","article-title":"Identification of novel targets for PGC-1\u03b1 and histone deacetylase inhibitors in neuroblastoma cells","volume":"379","author":"Cowell","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2020.01.001_bib70","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.01.026","article-title":"PGC-1\u03b1 regulates the mitochondrial antioxidant defense system in vascular endothelial cells","volume":"66","author":"Valle","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2020.01.001_bib71","article-title":"Protective role of PGC-1\u03b1 in diabetic nephropathy is associated with the inhibition of ROS through mitochondrial dynamic remodeling","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2020.01.001_bib72","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neubiorev.2019.01.001","article-title":"Down syndrome: neurobiological alterations and therapeutic targets","volume":"98","author":"Vacca","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.apsb.2020.01.001_bib73","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1093\/hmg\/ddu157","article-title":"NRIP1\/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome","volume":"23","author":"Izzo","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.apsb.2020.01.001_bib74","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bbadis.2016.03.003","article-title":"The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model","volume":"1862","author":"Valenti","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2020.01.001_bib75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2017.08.014","article-title":"Mitochondria as pharmacological targets in Down syndrome","volume":"114","author":"Valenti","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib76","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","article-title":"PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure","volume":"20","author":"Cant\u00f3","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.apsb.2020.01.001_bib77","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","article-title":"AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1\u03b1","volume":"104","author":"J\u00e4ger","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2020.01.001_bib78","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1\u03b1 and SIRT1","volume":"434","author":"Rodgers","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.01.001_bib79","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/bph.12413","article-title":"Turn up the power\u2014pharmacological activation of mitochondrial biogenesis in mouse models","volume":"171","author":"Komen","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2020.01.001_bib80","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1126\/science.1117728","article-title":"Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS","volume":"310","author":"Nisoli","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.apsb.2020.01.001_bib81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fcell.2015.00006","article-title":"Nitric oxide, interorganelle communication, and energy flow: a novel route to slow aging","volume":"3","author":"Valerio","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.apsb.2020.01.001_bib82","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1016\/j.bbadis.2017.09.014","article-title":"Inhibition of Drp1-mediated mitochondrial fission improves mitochondrial dynamics and bioenergetics stimulating neurogenesis in hippocampal progenitor cells from a Down syndrome mouse model","volume":"1863","author":"Valenti","year":"2017","journal-title":"Biochim Biophys Acta (BBA) \u2013 Mol Basis Dis"},{"key":"10.1016\/j.apsb.2020.01.001_bib83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10540-007-9038-z","article-title":"Mitochondria and neurodegeneration","volume":"27","author":"Petrozzi","year":"2007","journal-title":"Biosci Rep"},{"key":"10.1016\/j.apsb.2020.01.001_bib84","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.mehy.2007.01.017","article-title":"Mitochondria biogenesis induced by resveratrol against brain ischemic stroke","volume":"69","author":"Dong","year":"2007","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.apsb.2020.01.001_bib85","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1\u03b1","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2020.01.001_bib86","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neubiorev.2016.10.023","article-title":"Plant polyphenols as natural drugs for the management of Down syndrome and related disorders","volume":"71","author":"Vacca","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.apsb.2020.01.001_bib87","first-page":"1056","article-title":"Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells","volume":"26","author":"Izzo","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.apsb.2020.01.001_bib88","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1096\/fj.04-1980com","article-title":"Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy","volume":"19","author":"Timmons","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2020.01.001_bib89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-510X(98)00258-5","article-title":"Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state","volume":"161","author":"Disatnik","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.apsb.2020.01.001_bib90","series-title":"Robbins and Cotran pathologic basis of disease, professional edition","author":"Kumar","year":"2014"},{"key":"10.1016\/j.apsb.2020.01.001_bib91","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.it.2013.04.002","article-title":"Living and dying for inflammation: neutrophils, eosinophils, basophils","volume":"34","author":"Geering","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2020.01.001_bib92","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.01.001_bib93","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.bor.0000179948.65895.1a","article-title":"Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis","volume":"17","author":"Tidball","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.apsb.2020.01.001_bib94","doi-asserted-by":"crossref","first-page":"540370","DOI":"10.1155\/2013\/540370","article-title":"Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy","volume":"2013","author":"De Paepe","year":"2013","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.apsb.2020.01.001_bib95","doi-asserted-by":"crossref","first-page":"E713","DOI":"10.3390\/nu8110713","article-title":"Nutraceuticals and their potential to treat Duchenne muscular dystrophy: separating the credible from the conjecture","volume":"8","author":"Woodman","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2020.01.001_bib96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00281-013-0406-4","article-title":"Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology","volume":"36","author":"Eisele","year":"2014","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.apsb.2020.01.001_bib97","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/ars.2009.2940","article-title":"PGC-1\u03b1 regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload","volume":"13","author":"Lu","year":"2010","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.apsb.2020.01.001_bib98","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1172\/JCI58662","article-title":"PGC-1\u03b1 promotes recovery after acute kidney injury during systemic inflammation in mice","volume":"121","author":"Tran","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2020.01.001_bib99","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1152\/ajpendo.00205.2003","article-title":"Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response","volume":"286","author":"Feingold","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2020.01.001_bib100","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1194\/jlr.M500217-JLR200","article-title":"Suppression of estrogen-related receptor alpha and medium-chain acyl-coenzyme A dehydrogenase in the acute-phase response","volume":"46","author":"Kim","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2020.01.001_bib101","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.2337\/db05-1494","article-title":"Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1\/2 and nuclear factor-kappaB activation","volume":"55","author":"Coll","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2020.01.001_bib102","doi-asserted-by":"crossref","first-page":"E433","DOI":"10.1152\/ajpendo.2000.279.2.E433","article-title":"Impact of endotoxin on UCP homolog mRNA abundance, thermoregulation, and mitochondrial proton leak kinetics","volume":"279","author":"Yu","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2020.01.001_bib103","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.bbadis.2013.03.018","article-title":"Regulation of skeletal muscle oxidative phenotype by classical NF-\u03baB signalling","volume":"1832","author":"Remels","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2020.01.001_bib104","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jcp.21955","article-title":"TNF-\u03b1-mediated reduction in PGC-1\u03b1 may impair skeletal muscle function after cigarette smoke exposure","volume":"222","author":"Tang","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.apsb.2020.01.001_bib105","first-page":"5052","article-title":"TNF-\u03b1 impairs regulation of muscle oxidative\u00a0phenotype: implications for cachexia?.","volume":"24","author":"Remels","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2020.01.001_bib106","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1172\/JCI31785","article-title":"Abnormal glucose homeostasis in skeletal muscle-specific PGC-1\u03b1 knockout mice reveals skeletal muscle-pancreatic \u03b2 cell crosstalk","volume":"117","author":"Handschin","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2020.01.001_bib107","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1074\/jbc.M112.375253","article-title":"The peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1\/\u03b2 (PGC-1) coactivators repress the transcriptional activity of NF-\u03baB in skeletal muscle cells","volume":"288","author":"Eisele","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2020.01.001_bib108","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bbrc.2015.06.166","article-title":"The PGC-1 coactivators promote an anti-inflammatory environment in skeletal muscle in\u00a0vivo","volume":"464","author":"Eisele","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2020.01.001_bib109","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/iub.1470","article-title":"PGC-1\u03b2 suppresses saturated fatty acid-induced macrophage inflammation by inhibiting TAK1 activation","volume":"68","author":"Chen","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.apsb.2020.01.001_bib110","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1113\/JP274489","article-title":"Angiogenesis during pregnancy: all routes lead to MAPKs","volume":"595","author":"Hu","year":"2017","journal-title":"J Physiol"},{"key":"10.1016\/j.apsb.2020.01.001_bib111","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/med.21452","article-title":"Tumor angiogenesis revisited: regulators and clinical implications","volume":"37","author":"Ronca","year":"2017","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2020.01.001_bib112","series-title":"Animal models of exercise therapy: mechanisms of activity-induced angiogenesis [dissertation]","author":"Kissane","year":"2017"},{"key":"10.1016\/j.apsb.2020.01.001_bib113","doi-asserted-by":"crossref","first-page":"21401","DOI":"10.1073\/pnas.0909131106","article-title":"The transcriptional coactivator PGC-1\u03b1 mediates exercise-induced angiogenesis in skeletal muscle","volume":"106","author":"Chinsomboon","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2020.01.001_bib114","doi-asserted-by":"crossref","first-page":"C572","DOI":"10.1152\/ajpcell.00481.2009","article-title":"PGC-1\u03b1 plays a functional role in exercise-induced mitochondrial biogenesis and angiogenesis but not fiber-type transformation in mouse skeletal muscle","volume":"298","author":"Geng","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.apsb.2020.01.001_bib115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/db11-1271","article-title":"Peroxisome proliferator-activated receptor-\u03b3 coactivator-1\u03b1 (PGC-1\u03b1) enhances engraftment and angiogenesis of mesenchymal stem cells in diabetic hindlimb ischemia","volume":"61","author":"Lu","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2020.01.001_bib116","doi-asserted-by":"crossref","first-page":"8810","DOI":"10.1074\/jbc.M114.554394","article-title":"Hypoxic induction of vascular endothelial growth factor (VEGF) and angiogenesis in muscle by truncated peroxisome proliferator-activated receptor \u03b3 coactivator (PGC)-1\u03b1","volume":"289","author":"Thom","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2020.01.001_bib117","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nature06613","article-title":"HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1\u03b1","volume":"451","author":"Arany","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2020.01.001_bib118","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1152\/ajpendo.00076.2009","article-title":"PGC-1\u03b1 mediates exercise-induced skeletal muscle VEGF expression in mice","volume":"297","author":"Leick","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2020.01.001_bib119","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1152\/ajpendo.00681.2010","article-title":"PGC-1\u03b2 regulates angiogenesis in skeletal muscle","volume":"301","author":"Rowe","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2020.01.001_bib120","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.celrep.2018.02.047","article-title":"ERR\u03b3 promotes angiogenesis, mitochondrial biogenesis, and oxidative\u00a0remodeling in PGC1\u03b1\/\u03b2-deficient muscle","volume":"22","author":"Fan","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2020.01.001_bib121","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/biof.34","article-title":"Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (\u2013)-epigallocatechin gallate","volume":"35","author":"Dorchies","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.apsb.2020.01.001_bib122","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00418-008-0390-2","article-title":"Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and\u00a0electrophysiological study","volume":"129","author":"Nakae","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.apsb.2020.01.001_bib123","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ajcn\/75.4.749","article-title":"Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species","volume":"75","author":"Buetler","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.apsb.2020.01.001_bib124","doi-asserted-by":"crossref","first-page":"C616","DOI":"10.1152\/ajpcell.00425.2005","article-title":"Green tea extract and its major polyphenol (\u2013)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy","volume":"290","author":"Dorchies","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.apsb.2020.01.001_bib125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1472-6882-12-82","article-title":"Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1\/PGC-1\u03b1 signaling pathway","volume":"12","author":"Ye","year":"2012","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.apsb.2020.01.001_bib126","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.omtn.2018.02.004","article-title":"Saponins as natural adjuvant for antisense morpholino oligonucleotides delivery in\u00a0vitro and in mdx mice","volume":"11","author":"Wang","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.apsb.2020.01.001_bib127","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1139\/cjpp-2015-0262","article-title":"Chikusetsu saponin V attenuates H2O2-induced oxidative stress in human neuroblastoma SH-SY5Y cells through Sirt1\/PGC-1\u03b1\/Mn-SOD signaling pathways","volume":"94","author":"Wan","year":"2016","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.apsb.2020.01.001_bib128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jep.2011.12.024","article-title":"Cardioprotective effects of saponins from Panax japonicus on acute myocardial ischemia against oxidative stress-triggered damage and cardiac cell death in rats","volume":"140","author":"He","year":"2012","journal-title":"J Etnopharmacol"},{"key":"10.1016\/j.apsb.2020.01.001_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073875","article-title":"Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress","volume":"8","author":"Hori","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2020.01.001_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030063","article-title":"Rescue of dystrophic skeletal muscle by PGC-1\u03b1 involves a fast to slow fiber type shift in the mdx mouse","volume":"7","author":"Selsby","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2020.01.001_bib131","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1124\/jpet.111.183210","article-title":"Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy","volume":"338","author":"Hori","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.apsb.2020.01.001_bib132","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1139\/cjpp-2013-0350","article-title":"Resveratrol improves muscle function but not oxidative capacity in young mdx mice","volume":"92","author":"Gordon","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.apsb.2020.01.001_bib133","doi-asserted-by":"crossref","first-page":"837042","DOI":"10.1155\/2015\/837042","article-title":"Properties of resveratrol: in\u00a0vitro and in\u00a0vivo studies about metabolism, bioavailability, and biological effects in animal models and humans","volume":"2015","author":"Gambini","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.apsb.2020.01.001_bib134","doi-asserted-by":"crossref","first-page":"C66","DOI":"10.1152\/ajpcell.00357.2013","article-title":"Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1\u2013PGC-1\u03b1 axis","volume":"307","author":"Ljubicic","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.apsb.2020.01.001_bib135","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1074\/jbc.M112.392050","article-title":"Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1-mediated modulation of p300","volume":"288","author":"Kuno","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2020.01.001_bib136","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.clnu.2014.06.008","article-title":"Long-term quercetin dietary enrichment decreases muscle injury in mdx mice","volume":"34","author":"Hollinger","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.apsb.2020.01.001_bib137","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/mus.20579","article-title":"Progressive nuclear factor-\u03baB activation resistant to inhibition by contraction and curcumin in mdx mice","volume":"34","author":"Durham","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.apsb.2020.01.001_bib138","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1016-8478(23)17614-X","article-title":"Curcumin alleviates dystrophic muscle pathology in mdx mice","volume":"25","author":"Pan","year":"2008","journal-title":"Mol Cells"},{"key":"10.1016\/j.apsb.2020.01.001_bib139","doi-asserted-by":"crossref","first-page":"19201","DOI":"10.18632\/oncotarget.8450","article-title":"Curcumin elevates sirtuin level but does not postpone in\u00a0vitro senescence of human cells building the vasculature","volume":"7","author":"Grabowska","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2020.01.001_bib140","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1073\/pnas.171184698","article-title":"Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor","volume":"98","author":"Knutti","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2020.01.001_bib141","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1474-9726.2007.00357.x","article-title":"Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response","volume":"7","author":"Anderson","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.apsb.2020.01.001_bib142","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbior.2017.05.005","article-title":"Regulation of GSK-3 activity by curcumin, berberine and resveratrol: potential effects on multiple diseases","volume":"65","author":"McCubrey","year":"2017","journal-title":"Adv Biol Regul"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383519306057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383519306057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:41:59Z","timestamp":1761928919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383519306057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":141,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2211383519306057"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2020.01.001","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural products, PGC-1\u03b1, and Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}